- Home
- MKZR vs ADVB Comparison
MKZR vs ADVB Comparison
Compare MKZR & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- ADVB
- Stock Information
- Founded
- MKZR 2012
- ADVB 2014
- Country
- MKZR United States
- ADVB United States
- Employees
- MKZR N/A
- ADVB N/A
- Industry
- MKZR
- ADVB Medical Specialities
- Sector
- MKZR
- ADVB Health Care
- Exchange
- MKZR Nasdaq
- ADVB Nasdaq
- Market Cap
- MKZR 10.3M
- ADVB 9.1M
- IPO Year
- MKZR N/A
- ADVB 2025
- Fundamental
- Price
- MKZR $5.78
- ADVB $0.42
- Analyst Decision
- MKZR
- ADVB
- Analyst Count
- MKZR 0
- ADVB 0
- Target Price
- MKZR N/A
- ADVB N/A
- AVG Volume (30 Days)
- MKZR 69.1K
- ADVB 371.2K
- Earning Date
- MKZR 09-19-2025
- ADVB 11-03-2025
- Dividend Yield
- MKZR 38.99%
- ADVB N/A
- EPS Growth
- MKZR N/A
- ADVB N/A
- EPS
- MKZR N/A
- ADVB N/A
- Revenue
- MKZR $23,037,348.00
- ADVB N/A
- Revenue This Year
- MKZR N/A
- ADVB N/A
- Revenue Next Year
- MKZR N/A
- ADVB N/A
- P/E Ratio
- MKZR N/A
- ADVB N/A
- Revenue Growth
- MKZR 52.64
- ADVB N/A
- 52 Week Low
- MKZR $3.89
- ADVB $0.34
- 52 Week High
- MKZR $55.00
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- MKZR 50.44
- ADVB N/A
- Support Level
- MKZR $4.76
- ADVB N/A
- Resistance Level
- MKZR $6.40
- ADVB N/A
- Average True Range (ATR)
- MKZR 0.42
- ADVB 0.00
- MACD
- MKZR 0.12
- ADVB 0.00
- Stochastic Oscillator
- MKZR 62.01
- ADVB 0.00
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.